Company Overview of Naryx Pharma, Inc.
Naryx Pharma, Inc., a specialty pharmaceutical company, develops new therapies for patients with chronic sinusitis. Its products include Sybryx, which is used for the treatment of chronic sinusitis. The company focuses on development of inhaled, nebulized, and intranasal drug formulations. The company was formerly known as SinusPharma, Inc. and changed its name to Naryx Pharma, Inc. in March, 2005. Naryx Pharma, Inc. was founded in 1999 and is based in Carpinteria, California.
5464 Carpinteria Avenue
Carpinteria, CA 93013
Founded in 1999
Key Executives for Naryx Pharma, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|Tax Management Inc||United States|
|NYC2012, Inc.||United States|
|John F. Kennedy Center For The Performing Arts||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Naryx Pharma, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.